IS6567A - Sodium-hydrogen type 1 interlayer (NHE-1) - Google Patents

Sodium-hydrogen type 1 interlayer (NHE-1)

Info

Publication number
IS6567A
IS6567A IS6567A IS6567A IS6567A IS 6567 A IS6567 A IS 6567A IS 6567 A IS6567 A IS 6567A IS 6567 A IS6567 A IS 6567A IS 6567 A IS6567 A IS 6567A
Authority
IS
Iceland
Prior art keywords
nhe
interlayer
sodium
hydrogen type
hydrogen
Prior art date
Application number
IS6567A
Other languages
Icelandic (is)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6567A publication Critical patent/IS6567A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6567A 2000-04-28 2002-09-24 Sodium-hydrogen type 1 interlayer (NHE-1) IS6567A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
IS6567A true IS6567A (en) 2002-09-24

Family

ID=22741697

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6567A IS6567A (en) 2000-04-28 2002-09-24 Sodium-hydrogen type 1 interlayer (NHE-1)
IS6588A IS6588A (en) 2000-04-28 2002-10-21 Sodium-hydrogen alternate type 1 inhibitor (NHE-1)

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS6588A IS6588A (en) 2000-04-28 2002-10-21 Sodium-hydrogen alternate type 1 inhibitor (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (en) * 2001-12-19 2004-08-12 Pfizer Prod Inc Methods for preparing sodium-hydrogen exchanger type-1 inhibitors.
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
CA2515939A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504546A (en) * 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク N-[(substituted 5- or diazatriunsaturated) carbonyl] guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
ZA200208605B (en) 2003-10-24
UY26680A1 (en) 2001-12-28
HRP20020851A2 (en) 2005-02-28
MXPA02010600A (en) 2003-03-10
CN1426404A (en) 2003-06-25
GT200100064A (en) 2002-03-22
HN2001000042A (en) 2001-07-09
MA26897A1 (en) 2004-12-20
YU79602A (en) 2006-05-25
CR6797A (en) 2004-05-17
EP1276737A1 (en) 2003-01-22
CO5221125A1 (en) 2002-11-28
IL152075A0 (en) 2003-05-29
BG107139A (en) 2003-07-31
WO2001083470A1 (en) 2001-11-08
JP2003531900A (en) 2003-10-28
MY133842A (en) 2007-11-30
NZ521348A (en) 2004-09-24
UA73348C2 (en) 2005-07-15
IS6588A (en) 2002-10-21
TR200202439T2 (en) 2003-02-21
BR0110268A (en) 2003-12-30
EE200200615A (en) 2004-04-15
PL357765A1 (en) 2004-07-26
SV2002000418A (en) 2002-07-03
AR028375A1 (en) 2003-05-07
AU2001235896A1 (en) 2001-11-12
PE20011270A1 (en) 2001-12-12
PA8513301A1 (en) 2003-09-05
NO20025132L (en) 2002-12-12
OA12256A (en) 2003-11-06
AP2002002651A0 (en) 2002-12-31
CA2407535A1 (en) 2001-11-08
CZ20023408A3 (en) 2004-01-14
CN1225466C (en) 2005-11-02
DZ3310A1 (en) 2001-11-07
KR20020093079A (en) 2002-12-12
EA200201023A1 (en) 2003-02-27
HUP0300651A2 (en) 2003-07-28
SK14872002A3 (en) 2004-03-02
NO20025132D0 (en) 2002-10-25
TNSN01065A1 (en) 2005-11-10
EA004882B1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
NO20030845L (en) Selected condensed pyrrolocarbazoles
DE60143412D1 (en) router
DE60129364D1 (en) fuse
DE60122878D1 (en) FUSE
FR2818008B1 (en) MODULAR FUSE HOLDER
DK1226127T3 (en) Substituted phenylsulfamoylcarboxamides
DE60114153D1 (en) SUBSTITUTED ARYLPYRAZINE
AR028393A1 (en) SUBSTITUTED IMINOAZIDS
DE50110260D1 (en) COOLING CIRCUIT
FI20002408L (en) Cooling element
DE50112662D1 (en) SUBSTITUTED BENZOYLCYCLOHEXENONE
FI20002454A0 (en) Heat
NO20012448L (en) Stigerördiameter selector
DE60127966D1 (en) CIRCUIT
IS6588A (en) Sodium-hydrogen alternate type 1 inhibitor (NHE-1)
FR2815472B1 (en) DIAC PLANAR
DE60122192D1 (en) CIRCUIT
EP1273914A4 (en) hypotensive
DE50101588D1 (en) clamp
DE69903130D1 (en) FOLD-OUT IRONING TABLE
DE60112941D1 (en) CIRCUIT
FI19992301L (en) Z-motor
DE60117837D1 (en) CIRCUIT
DE60113842D1 (en) CIRCUIT
FI20002648A0 (en) Heat